| |
| |
|
| Insider
Information: |
Flanagan Robert J |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
13,510 |
|
|
Indirect Shares
|
805,792 |
|
|
| Direct
Value |
$792,632 |
|
|
|
Indirect Value
|
$1,015,298 |
|
|
| Total
Shares |
819,302 |
|
|
| Total
Value |
$1,807,930 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -14.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Martek Biosciences Corp |
MATK |
Director |
2011-02-25 |
0 |
2011-02-18 |
0 |
Premium* |
|
|
Castle Brands Inc |
ROX |
Director |
|
0 |
2007-05-08 |
805,792 |
Premium* |
|
|
Sagent Pharmaceuticals Inc |
SGNT |
Director |
2016-08-29 |
0 |
2016-08-29 |
0 |
Premium* |
|
|
WP Carey & Co |
WPC |
Director |
2023-07-03 |
13,510 |
2018-04-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
72 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MATK |
Martek Biosciences Corp |
Director |
– • – |
2003-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
114 |
114 |
|
- |
|
| MATK |
Martek Biosciences Corp |
Director |
– • – |
2003-07-03 |
4 |
A |
$0.00 |
$0 |
I/I |
27,290 |
310,268 |
|
- |
|
| ROX |
Castle Brands Inc |
Director |
– • – |
2006-04-10 |
4 |
A |
$0.00 |
$0 |
I/I |
552,320 |
618,287 |
|
- |
|
| MATK |
Martek Biosciences Corp |
Director |
– • – |
2007-10-15 |
4 |
A |
$0.00 |
$0 |
I/I |
25,341 |
332,609 |
0 |
- |
|
| MATK |
Martek Biosciences Corp |
Director |
– • – |
2007-10-15 |
4 |
A |
$0.00 |
$0 |
D/D |
105 |
219 |
0 |
- |
|
| MATK |
Martek Biosciences Corp |
Director |
– • – |
2011-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
2,533 |
2,533 |
0 |
- |
|
| WPC |
WP Carey & Co |
Director |
– • – |
2018-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
327 |
327 |
0 |
- |
|
| WPC |
WP Carey & Co |
Director |
– • – |
2018-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,523 |
1,850 |
0 |
- |
|
| WPC |
WP Carey & Co |
Director |
– • – |
2019-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,867 |
3,717 |
0 |
- |
|
| WPC |
WP Carey & Co |
Director |
– • – |
2020-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,180 |
6,897 |
0 |
- |
|
| WPC |
WP Carey & Co |
Director |
– • – |
2021-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,141 |
9,038 |
0 |
- |
|
| WPC |
WP Carey & Co |
Director |
– • – |
2022-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,919 |
10,957 |
0 |
- |
|
| WPC |
WP Carey & Co |
Director |
– • – |
2023-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,553 |
13,510 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2014-07-30 |
4 |
AS |
$26.00 |
$208,000 |
I/I |
(8,000) |
529,770 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2014-07-31 |
4 |
AS |
$25.20 |
$201,600 |
I/I |
(8,000) |
521,770 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2014-08-11 |
4 |
AS |
$24.39 |
$195,120 |
I/I |
(8,000) |
513,770 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2014-08-12 |
4 |
AS |
$24.39 |
$195,120 |
I/I |
(8,000) |
505,770 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2014-08-27 |
4 |
AS |
$27.30 |
$218,400 |
I/I |
(8,000) |
497,770 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2014-08-28 |
4 |
AS |
$27.07 |
$216,560 |
I/I |
(8,000) |
489,770 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2014-09-11 |
4 |
AS |
$28.35 |
$226,800 |
I/I |
(8,000) |
481,770 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2014-09-12 |
4 |
AS |
$28.25 |
$226,000 |
I/I |
(8,000) |
473,770 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2014-09-24 |
4 |
AS |
$30.30 |
$242,400 |
I/I |
(8,000) |
465,770 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2014-09-25 |
4 |
AS |
$29.72 |
$237,760 |
I/I |
(8,000) |
457,770 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2014-10-07 |
4 |
AS |
$31.15 |
$249,200 |
I/I |
(8,000) |
449,770 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2014-10-08 |
4 |
AS |
$31.96 |
$255,680 |
I/I |
(8,000) |
441,770 |
0 |
- |
|
72 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
